Back to Search Start Over

PB1762: ponatinib versus imatinib with reduced-intensity chemotherapy in patients with newly diagnosed philadelphia chromosome–positive (ph+) acute lymphoblastic leukemia (all): phallcon study

Authors :
Jabbour, E.
Martinelli, G.
Vignetti, M.
Kantarjian, Hagop M.
Gómez Almaguer, David
Minami, Y.
Dombret, H.
Hennessy, M.
Vorog, A.
Wang, B.
Ribera, J. M.
Jabbour, E.
Martinelli, G.
Vignetti, M.
Kantarjian, Hagop M.
Gómez Almaguer, David
Minami, Y.
Dombret, H.
Hennessy, M.
Vorog, A.
Wang, B.
Ribera, J. M.
Publication Year :
2022

Details

Database :
OAIster
Notes :
text, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1355845832
Document Type :
Electronic Resource

Tools

Authors Abstract Subjects Details